Preclinical and clinical studies showed that treatment with tadalafil, an inhibitor of phosphodiesterase-5 (PDE5), significantly inhibited MDSCs’ suppressive functions by the downregulation of iNOS and ARG1, boosting tumor-specific immunity [17,125]. The gene discussed is NOS2; the disease is neoplasm.